  See all
 |
Articles: Neuro/Psych pharmacology |
Prior Articles
Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action
European Neuropsychopharmacology, 09/15/09
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Pharmacology & Therapeutics, 09/15/09 The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Trends in Pharmacological Sciences, 09/15/09 A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke. Modified Randomized Exposure Controlled Trial (mRECT)
Stroke, 09/14/09 Antidepressant use and colorectal cancer risk
Pharmacoepidemiology and Drug Safety, 09/14/09 Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation
Drugs & Aging, 09/14/09 Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
Neuropsychiatric Disease and Treatment, 09/14/09
Free full text
Intranasal delivery of ESBA105, a TNF-alpha-inhibitory scFv antibody fragment to the brain
Journal of Neuroimmunology, 09/14/09 Kappa-opioid ligands in the study and treatment of mood disorders
Pharmacology & Therapeutics, 09/14/09 Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database
Pharmacoepidemiology and Drug Safety, 09/14/09 Few pharmacological options available for treating cognitive impairment associated with severe Alzheimer's disease
Drugs & Therapy Perspectives, 09/11/09 Pilocarpine-Induced Seizures Revisited: What Does the Model Mimic
Epilepsy Currents, 09/11/09 250 mug or 500 mug interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
The Lancet Neurology, 09/10/09 Treatment of Progressive Stroke with Tirofiban - Experience in 35 Patients
Cerebrovascular Diseases, 09/10/09 A Randomized, Double-Blind, Placebo-Controlled Study of Topiramate in the Treatment of Tourette Syndrome
Journal of Neurology, Neurosurgery, and Psychiatry, 09/10/09 Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
The Lancet Neurology, 09/10/09 Pharmacogenetic Testing for Guiding de novo Phenprocoumon Therapy in Stroke Patients
Cerebrovascular Diseases, 09/10/09 Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: An open-label prospective study
World Journal of Biological Psychiatry, 09/10/09 Selective Boosting of Transcriptional and Behavioral Responses to Drugs of Abuse by Histone Deacetylase Inhibition
Neuropsychopharmacology, 09/10/09 Pharmacogenomics of antidepressant drugs
Pharmacology & Therapeutics, 09/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
250 Available Pages
|
|
